Drug insight: testosterone preparations
- PMID: 17149382
- DOI: 10.1038/ncpuro0650
Drug insight: testosterone preparations
Abstract
Testosterone has been used for substitution therapy in testicular and hypothalamopituitary diseases for almost six decades, with injectable testosterone esters and implanted testosterone pellets being the mainstay of treatment. Growing interest in the possible use of testosterone in nonclassical situations such as male contraception, aging (late-onset hypogonadism), muscle-wasting conditions like HIV, erectile dysfunction, and female hypoactive sexual disorder has stimulated research, leading to the development of several new modes of administration of testosterone. Transdermal patches, gels, mucoadhesive sustained-release buccal tablets and long-acting testosterone esters are designed to provide testosterone levels that approximate normal physiologic levels, to improve patient acceptability, and to further increase the number of treatment options available. In this Review, we briefly describe the chemistry, mechanism of action, and metabolism of testosterone. We then discuss the pharmacokinetics, advantages, and disadvantages of various formulations and summarize the various preparations currently available.
Similar articles
-
Testosterone treatment in elderly men.Adv Ther. 2009 Jan;26(1):25-39. doi: 10.1007/s12325-008-0137-4. Epub 2009 Jan 27. Adv Ther. 2009. PMID: 19198768 Review.
-
Testosterone replacement therapy: current trends and future directions.Hum Reprod Update. 2004 Sep-Oct;10(5):409-19. doi: 10.1093/humupd/dmh035. Epub 2004 Aug 5. Hum Reprod Update. 2004. PMID: 15297434 Review.
-
Testosterone treatment comes of age: new options for hypogonadal men.Clin Endocrinol (Oxf). 2006 Sep;65(3):275-81. doi: 10.1111/j.1365-2265.2006.02618.x. Clin Endocrinol (Oxf). 2006. PMID: 16918944 Review.
-
Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder.Int J Impot Res. 2007 Sep-Oct;19(5):458-63. doi: 10.1038/sj.ijir.3901558. Epub 2007 Jun 21. Int J Impot Res. 2007. PMID: 17581596 Review.
-
Testosterone therapy for sexual dysfunction in postmenopausal women.Climacteric. 2008 Jun;11(3):181-91. doi: 10.1080/13697130802162822. Climacteric. 2008. PMID: 18568783 Review.
Cited by
-
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):153-161. doi: 10.1007/s13539-011-0034-6. Epub 2011 Aug 2. J Cachexia Sarcopenia Muscle. 2011. PMID: 22031847 Free PMC article.
-
Androgens and Anemia: Current Trends and Future Prospects.Front Endocrinol (Lausanne). 2019 Nov 14;10:754. doi: 10.3389/fendo.2019.00754. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31798530 Free PMC article. No abstract available.
-
Advances in male contraception.Endocr Rev. 2008 Jun;29(4):465-93. doi: 10.1210/er.2007-0041. Epub 2008 Apr 24. Endocr Rev. 2008. PMID: 18436704 Free PMC article. Review.
-
Intramuscularly injected long-acting testosterone-cholesterol prodrug suspension with three different particle sizes: extended in vitro release and enhanced in vivo safety.Drug Deliv Transl Res. 2024 Apr;14(4):1093-1105. doi: 10.1007/s13346-023-01460-2. Epub 2023 Nov 6. Drug Deliv Transl Res. 2024. PMID: 37932630
-
CYB561 supports the neuroendocrine phenotype in castration-resistant prostate cancer.PLoS One. 2024 May 13;19(5):e0300413. doi: 10.1371/journal.pone.0300413. eCollection 2024. PLoS One. 2024. PMID: 38739593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources